Albertini M, Haas H, Chiche V, Bourrier T, Dageville C, Mariani R
Service de Pédiatrie, Hôpital de Cimiez, Nice.
Rev Mal Respir. 1996 Jul;13(3):273-9.
Sensitisation to non tuberculous mycobacteria (NTM) may provoke a non specific tuberculin reaction and can cause problems in the interpretation of tuberculin tests in subjects who have not been vaccinated with BCG. The practice of testing for antigens to NTM (sensitins) should be useful for pointing to the right diagnosis. Our study was carried out on 24 asymptomatic children aged between 11 months and 8 years 9 months; these children were considered to be sensitive to NTM based on comparative cutaneous tests (reactions to sensitins > or = 5 mm and > or = 3 mm vs tuberculin) and were selected from a group of 53 children who had either initially achieved a positive tuberculin reaction or who had undergone conversion on subsequent prevaccination testing. The tests were carried out with tuberculin RT 23, tuberculin Merieux and sensitins from M. avium and M. intracellulare. They had been repeated two to four months later in cases of a response to one of the different reactants. At the first examination the tuberculin reactions were most often weak, the Merieux tuberculin induced a stronger response than the RT23 tuberculin. A dominant response for one or both sensitins was present in 18 cases. The tuberculin reactions became weaker whilst the sensitins remained relatively stable. The difference became significant in the six remaining cases. Although tests for tuberculin and sensitins have some diagnostic value which is necessarily imprecise, comparative analysis of the cutaneous reactions to the different antigens may contribute to avoid an erroneous interpretation for tuberculin allergy in asymptomatic young children without any risk factors for tuberculous infection. It is important to identify those subjects having non specific tuberculin reactivity induced by sensitisation to NTM in order to avoid non justified chemoprophylaxis and also to be able to vaccinate these children with BCG.
对非结核分枝杆菌(NTM)致敏可能引发非特异性结核菌素反应,并可能在未接种卡介苗的受试者中导致结核菌素试验结果解读出现问题。检测NTM抗原(致敏素)的做法对于明确正确诊断应是有用的。我们对24名年龄在11个月至8岁9个月之间的无症状儿童进行了研究;根据比较皮肤试验(对致敏素的反应≥5毫米且对结核菌素反应≥3毫米),这些儿童被认为对NTM敏感,他们是从一组53名儿童中挑选出来的,这些儿童最初结核菌素反应呈阳性,或者在随后的接种前检测中出现了血清转换。试验使用了结核菌素RT 23、梅里埃结核菌素以及鸟分枝杆菌和胞内分枝杆菌的致敏素。如果对其中一种不同反应物有反应,则在两到四个月后重复进行试验。在首次检查时,结核菌素反应大多较弱,梅里埃结核菌素引发的反应比RT23结核菌素更强。18例出现对一种或两种致敏素的优势反应。结核菌素反应变弱,而致敏素反应相对稳定。在其余6例中差异变得显著。尽管结核菌素和致敏素检测具有一定的诊断价值,但必然不够精确,对不同抗原的皮肤反应进行比较分析可能有助于避免对无结核感染危险因素的无症状幼儿结核菌素过敏的错误解读。识别那些因对NTM致敏而具有非特异性结核菌素反应性的受试者很重要,以便避免不必要的化学预防,并且能够给这些儿童接种卡介苗。